Corange doubles stake in IRIS
This article was originally published in Clinica
Executive Summary
Corange, the parent of German diagnostics and pharma company Boehringer Mannheim, doubled its stake in IRIS to 8.3% through the exercise of a warrant, paying $932,000 in cash. IRIS - International Remote Imaging Systems - based in Los Angeles claims to be the leader in automated microscopic urinalysis.